Literature DB >> 33440621

Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report.

Maria Massucci1, Veronica Mollica1, Alessandro Rizzo1, Laura Ventrella2, Ilaria Maggio1, Lisa Manuzzi1, Lidia Gatto3, Giovanni Brandi4, Francesco Massari1.   

Abstract

Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with metastatic clear cell renal carcinoma undergoing treatment with sunitinib for two years that developed encephalic leukocytoclastic vasculitis, probably due to a paraneoplastic syndrome.

Entities:  

Keywords:  encephalic vasculitis; leukocytoclastic vasculitis; paraneoplastic syndrome; renal cell carcinoma (RCC); sunitinib

Year:  2021        PMID： 33440621      PMCID： PMC7826710          DOI： 10.3390/medicines8010005

Source DB:  PubMed          Journal:  Medicines (Basel)        ISSN： 2305-6320


  18 in total

1.  Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature.

Authors:  Gyula László Fekete; László Fekete
Journal:  Exp Ther Med       Date:  2018-11-19       Impact factor: 2.447

Review 2.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 3.  The epidemiology of renal cell carcinoma.

Authors:  Börje Ljungberg; Steven C Campbell; Han Yong Choi; Han Yong Cho; Didier Jacqmin; Jung Eun Lee; Steffen Weikert; Lambertus A Kiemeney
Journal:  Eur Urol       Date:  2011-07-05       Impact factor: 20.096

4.  Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.

Authors:  Ganesh S Palapattu; Blaine Kristo; Jacob Rajfer
Journal:  Rev Urol       Date:  2002

Review 5.  Sunitinib in the treatment of metastatic renal cell carcinoma.

Authors:  Thomas A Schmid; Martin E Gore
Journal:  Ther Adv Urol       Date:  2016-08-23

6.  Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.

Authors:  Matteo Santoni; Sebastiano Buti; Alessandro Conti; Camillo Porta; Giuseppe Procopio; Cora N Sternberg; Sergio Bracarda; Umberto Basso; Ugo De Giorgi; Mimma Rizzo; Lisa Derosa; Cinzia Ortega; Francesco Massari; Michele Milella; Melissa Bersanelli; Linda Cerbone; Giovanni Muzzonigro; Luciano Burattini; Rodolfo Montironi; Daniele Santini; Stefano Cascinu
Journal:  Target Oncol       Date:  2015-01-06       Impact factor: 4.493

Review 7.  Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.

Authors:  Naeem Bhojani; Claudio Jeldres; Jean-Jacques Patard; Paul Perrotte; Nazareno Suardi; Georg Hutterer; François Patenaude; Stéphane Oudard; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2007-11-26       Impact factor: 20.096

8.  Leukocytoclastic vasculitis after long-term treatment with sunitinib: a case report.

Authors:  Alexandra Karadimou; Magdalini Migou; Afroditi Economidi; Alexandros Stratigos; Christos Kittas; Meletios A Dimopoulos; Aristotle Bamias
Journal:  Case Rep Oncol       Date:  2011-08-18

9.  Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein.

Authors:  Tamio Okimoto; Yukari Tsubata; Takamasa Hotta; Megumi Hamaguchi; Takae Okuno; Yohei Shiratsuki; Akari Kodama; Mika Nakao; Yoshihiro Amano; Shunichi Hamaguchi; Noriaki Kurimoto; Reiko Tobita; Takeshi Isobe
Journal:  Oncotarget       Date:  2018-04-13

10.  Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Francesco Massari; Veronica Mollica; Alessandro Rizzo; Laura Cosmai; Mimma Rizzo; Camillo Porta
Journal:  Expert Opin Drug Saf       Date:  2020-09-08       Impact factor: 4.250
View more
  1 in total

1.  Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma.

Authors:  Laura Burgess; Marissa Keenan; Alan Liang Zhou; Kiefer Lypka; Delvina Hasimja Saraqini; Jeff Yao; Samuel Martin; Christopher Morash; James Watterson; Christina Canil; Robert MacRae
Journal:  Curr Oncol       Date:  2021-05-07       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.